Clinical Trial Recruitment Australia: From Patient Traffic to Randomisation

Clinical trial recruitment in Australia is not a marketing problem. It is an operational alignment problem.

Sponsors need predictable enrolment.
CROs need measurable conversion.
Research sites need a manageable referral flow.
Patients need clarity and confidence.

When those elements are misaligned, recruitment volume increases but randomisation stalls.

Medimark was built to close that gap.

In December 2025, Paradigm Biopharmaceuticals referenced Medimark in its ASX announcement for the PARA_OA_012 Phase 3 trial, recognising our contribution to recruitment momentum. This reflects the impact of structured, protocol-aligned recruitment strategies in large-scale, multi-site trials across Australia.

‍

Measured Recruitment Outcomes

Over a focused three-month national recruitment initiative, Medimark supported:

• 13,000+ patient website visits
• ~3,000 completed digital pre-screen assessments

• ~1,000 referrals to Australian clinical trial sites
  
  

However, success was not defined by traffic.

It was defined by referral quality, eligibility alignment, and operational integration with participating research sites.

Each referral pathway was built around:

- Protocol-informed pre-screen logic

- Clear inclusion and exclusion education

- Geographic site matching

- Capacity-aware referral routing

This reduced screening friction and supported stronger site-level efficiency.

‍

Why Most Clinical Trial Recruitment Campaigns Underperform

Many digital recruitment strategies focus on awareness, social media reach, or paid advertising volume.

What they often neglect:

- Eligibility nuance

- Site capacity limitations

- Screening workflow realities

- Randomisation probability

Without structured integration between digital systems and site operations, recruitment volume overwhelms coordinators and increases screen failure rates.

More traffic does not equal more enrolled participants.

‍

The Medimark Clinical Trial Recruitment Framework

Medimark delivers structured clinical trial patient recruitment infrastructure across Australia, particularly for Phase 2 and Phase 3 studies.

Our model is built on four pillars:

1. Protocol-Aligned Digital Pre-Screening

Eligibility criteria are embedded into patient-facing systems before referral submission.

2. Structured Patient Education

Patients are guided through study expectations, timelines, and commitments to reduce drop-off and improve informed participation.

3. Data Segmentation and Continuous Optimisation

Recruitment campaigns are refined using site feedback and screening outcomes.

4. Operational Site Integration

Referral pathways are designed to support research coordinators, not disrupt them.

This is not simply digital advertising.
It is a structured recruitment system.

‍

Supporting Sponsors, CROs and Research Sites Across Australia

Medimark partners with:

• Clinical trial sponsors
• Contract Research Organisations (CROs)
• Independent and networked research sites
  
  

Our objective is not enquiry volume.

It is improved:

• Screening efficiency
• Referral quality
• Randomisation conversion
• Recruitment timeline stability
  
  

If you are planning an upcoming Phase 2 or Phase 3 study and require scalable, protocol-aligned recruitment support, our team can assist with structured patient pathways tailored to your trial design.

‍

Clinical Trial Recruitment Services at Medimark

Medimark provides:

• National digital recruitment strategy
• Structured pre-screen development
• Patient education pathway design
• Site-aligned referral routing
• Recruitment analytics and optimisation
  
  

Learn more about our
→ Clinical Trial Recruitment Services → Healthcare Marketing and Management → CPD Accredited Educational Events

These services integrate to support recruitment outcomes beyond surface-level metrics.

‍

Why Structured Recruitment Matters for Phase 3 Trials

Phase 3 clinical trials require:

- Multi-site coordination
- Higher enrolment volumes
- Commercial accountability
- Sponsor-level reporting confidence

Without operational alignment, digital recruitment can create more administrative burden than benefit. Structured systems create predictable recruitment momentum.

‍

Explore a Clinical Trial Recruitment Strategy

If you are a sponsor, CRO, or research site seeking clinical trial recruitment support in Australia, Medimark offers confidential strategy consultations to assess:

• Trial feasibility positioning
• Referral pathway design
• Screening efficiency opportunities
• National scalability planning
  
  

Contact Medimark to discuss how structured patient recruitment systems can support your upcoming clinical study.

‍